Tom Kindlon
Senior Member (Voting Rights)
From: Dr. Marc-Alexander Fluks
Sent: Thursday 28 December 2017 09:45
To: LOCALME <localme@yahoogroups.com>; MEACTIONUK <meactionuk@yahoogroups.com>; MECHAT-L <mechat-l@listserv.icors.org>; CFS-L <cfs-l@listserv.icors.org>; Colin Barton <colin.sussexme@btinternet.com>
Subject: Column: Alastair Miller
Source: Alastair Miller
Date: December 22, 2017
Author: Alastair Miller
I am a NHS consultant physician in Infectious Disease and General Internal Medicine who has been involved in the NHS evidence based management of CFS since my training as a registrar in the late 1980s. I was head of the large CFS service based within the Tropical & Infectious Disease Unit at the Royal Liverpool University hospital from 2006-2014 and prior to that had established and led the County wide service for CFS in Worcestershire. I was a founder member of the British Association for CFS & ME (BACME) and have recently stood down as chair of that organisation (the specialist society for all clinicians involved in the management of CFS) after 4 years. I was Principal Medical Adviser for Action for ME for 5 years.
The most destructive thing about the whole CFS agenda has been the two extreme opinions that this is either a purely physical illness with no psychological dimension or it is a pure psychological illness with no physiological basis. All the NHS clinicians with whom I have worked believe that there are elements of both physiological and psychological dysfunction in many patients with CFS and that this 'mind/body debate' is essentially a destructive distraction from getting on and offering best management for our patients. The fact that the behavioural approaches used in the PACE trial, supported by the current NICE guidelines and widely used in all NHS services are effective does not mean that CFS is 'all in the mind'. We know that some of the psychological approaches used in our clinics are also highly effective in relieving the symptoms of cancer or such chronic conditions as rheumatoid arthritis and clearly nobody would suggest that these conditions are 'all in the mind'. CFS is purely a symptomatic condition. If you have no symptoms you do not have CFS. Therefore if we can relieve/improve the symptoms we relieve the disease.
We know that not everyone is helped by the current NICE approved therapies but in my experience over the last 20 years many people are and there is currently no alternative therapy. Despite a huge investment into biomedical research for CFS, there is no unifying pathological mechanism identified to explain its many symptoms and no pharmacologic approach to therapy and therefore cognitive behaviour therapy (CBT) and Graded Exercise therapy (GET) as recommended by NICE remain currently the 'best that we have'. Clearly further trials need to continue to refine our therapeutic approaches and develop new ones.
Having been involved in working with patients over many years in the development of new therapies for HIV and hepatitis, I find that CFS is a most unusual condition where well meaning and dedicated researchers and clinicians find themselves at odds with patient activist groups rather than working constructively with them.
Alastair Miller
Consultant Physician
North Cumbria University Hospitals Trust
Sent: Thursday 28 December 2017 09:45
To: LOCALME <localme@yahoogroups.com>; MEACTIONUK <meactionuk@yahoogroups.com>; MECHAT-L <mechat-l@listserv.icors.org>; CFS-L <cfs-l@listserv.icors.org>; Colin Barton <colin.sussexme@btinternet.com>
Subject: Column: Alastair Miller
Source: Alastair Miller
Date: December 22, 2017
Author: Alastair Miller
I am a NHS consultant physician in Infectious Disease and General Internal Medicine who has been involved in the NHS evidence based management of CFS since my training as a registrar in the late 1980s. I was head of the large CFS service based within the Tropical & Infectious Disease Unit at the Royal Liverpool University hospital from 2006-2014 and prior to that had established and led the County wide service for CFS in Worcestershire. I was a founder member of the British Association for CFS & ME (BACME) and have recently stood down as chair of that organisation (the specialist society for all clinicians involved in the management of CFS) after 4 years. I was Principal Medical Adviser for Action for ME for 5 years.
The most destructive thing about the whole CFS agenda has been the two extreme opinions that this is either a purely physical illness with no psychological dimension or it is a pure psychological illness with no physiological basis. All the NHS clinicians with whom I have worked believe that there are elements of both physiological and psychological dysfunction in many patients with CFS and that this 'mind/body debate' is essentially a destructive distraction from getting on and offering best management for our patients. The fact that the behavioural approaches used in the PACE trial, supported by the current NICE guidelines and widely used in all NHS services are effective does not mean that CFS is 'all in the mind'. We know that some of the psychological approaches used in our clinics are also highly effective in relieving the symptoms of cancer or such chronic conditions as rheumatoid arthritis and clearly nobody would suggest that these conditions are 'all in the mind'. CFS is purely a symptomatic condition. If you have no symptoms you do not have CFS. Therefore if we can relieve/improve the symptoms we relieve the disease.
We know that not everyone is helped by the current NICE approved therapies but in my experience over the last 20 years many people are and there is currently no alternative therapy. Despite a huge investment into biomedical research for CFS, there is no unifying pathological mechanism identified to explain its many symptoms and no pharmacologic approach to therapy and therefore cognitive behaviour therapy (CBT) and Graded Exercise therapy (GET) as recommended by NICE remain currently the 'best that we have'. Clearly further trials need to continue to refine our therapeutic approaches and develop new ones.
Having been involved in working with patients over many years in the development of new therapies for HIV and hepatitis, I find that CFS is a most unusual condition where well meaning and dedicated researchers and clinicians find themselves at odds with patient activist groups rather than working constructively with them.
Alastair Miller
Consultant Physician
North Cumbria University Hospitals Trust